Histopathological effects of topical coenzyme q 10 + Vit E TPGS in experimental ischemic optic neuropathy

2022 ◽  
pp. 1-9
Author(s):  
Oğuzhan Oruz ◽  
Kemal Yar ◽  
Dilek Şaker ◽  
Arbil Açıkalın ◽  
Yusuf Kenan Dağlıoğlu ◽  
...  
Keyword(s):  
Optic Neuropathy ◽  
Coenzyme Q ◽  
Ischemic Optic Neuropathy ◽  
Histopathological Effects

Blood rheology in acute anterior ischemic optic neuropathy

1991 ◽  
Vol 11 (6) ◽  
pp. 623-634 ◽  
Author(s):  
B. Bertram ◽  
A. Hoberg ◽  
O. Arend ◽  
S. Wolf ◽  
F. Jung ◽  
...  
Keyword(s):  
Optic Neuropathy ◽  
Blood Rheology ◽  
Anterior Ischemic Optic Neuropathy ◽  
Ischemic Optic Neuropathy

Posterior Ischemic Optic Neuropathy Related to Profound Shock After Penetrating Thoracoabdominal Trauma

2002 ◽  
Vol 95 (9) ◽  
pp. 1053-1057 ◽  
Author(s):  
JUAN A. ASENSIO ◽  
WALTER FORNO ◽  
GUSTAVO A. ROLDÁN CASTILLO ◽  
ESTEBAN GAMBARO ◽  
PATRIZIO PETRONE
Keyword(s):  
Optic Neuropathy ◽  
Ischemic Optic Neuropathy ◽  
Posterior Ischemic Optic Neuropathy

scholarly journals Protective Effects of Oroxylin A on Retinal Ganglion Cells in Experimental Model of Anterior Ischemic Optic Neuropathy

Antioxidants ◽  
2021 ◽  
Vol 10 (6) ◽  
pp. 902
Author(s):  
Jia-Ying Chien ◽  
Shu-Fang Lin ◽  
Yu-Yau Chou ◽  
Chi-Ying F. Huang ◽  
Shun-Ping Huang
Keyword(s):  
Retinal Ganglion Cells ◽  
Optic Neuropathy ◽  
Ganglion Cells ◽  
Ischemic Injury ◽  
Anterior Ischemic Optic Neuropathy ◽  
Heme Oxygenase 1 ◽  
Related Factor ◽  
Ischemic Optic Neuropathy ◽  
Retinal Ganglion ◽  
Oroxylin A

Nonarteritic anterior ischemic optic neuropathy (NAION) is the most common cause of acute vision loss in older people, and there is no effective therapy. The effect of the systemic or local application of steroids for NAION patients remains controversial. Oroxylin A (OA) (5,7-dihydroxy-6-methoxyflavone) is a bioactive flavonoid extracted from Scutellariae baicalensis Georgi. with various beneficial effects, including anti-inflammatory and neuroprotective effects. A previous study showed that OA promotes retinal ganglion cell (RGC) survival after optic nerve (ON) crush injury. The purpose of this research was to further explore the potential actions of OA in ischemic injury in an experimental anterior ischemic optic neuropathy (rAION) rat model induced by photothrombosis. Our results show that OA efficiently attenuated ischemic injury in rats by reducing optic disc edema, the apoptotic death of retinal ganglion cells, and the infiltration of inflammatory cells. Moreover, OA significantly ameliorated the pathologic changes of demyelination, modulated microglial polarization, and preserved visual function after rAION induction. OA activated nuclear factor E2 related factor (Nrf2) signaling and its downstream antioxidant enzymes NAD(P)H:quinone oxidoreductase (NQO-1) and heme oxygenase 1 (HO-1) in the retina. We demonstrated that OA activates Nrf2 signaling, protecting retinal ganglion cells from ischemic injury, in the rAION model and could potentially be used as a therapeutic approach in ischemic optic neuropathy.

Intravitreal triamcinolone injections in non-arteritic anterior ischemic optic neuropathy

2013 ◽  
Vol 252 (2) ◽  
pp. 339-345 ◽  
Author(s):  
Corina Radoi ◽  
Tony Garcia ◽  
Catherine Brugniart ◽  
Alain Ducasse ◽  
Carl Arndt
Keyword(s):  
Optic Neuropathy ◽  
Anterior Ischemic Optic Neuropathy ◽  
Ischemic Optic Neuropathy ◽  
Intravitreal Triamcinolone

Tonic pupil, anterior ischemic optic neuropathy in a teenager with Takayasu arteritis

2013 ◽  
Vol 48 (6) ◽  
pp. e159-e163 ◽  
Author(s):  
Jyoti Matalia ◽  
Nirupama Kasturi ◽  
Hemant D. Anaspure ◽  
Bhujang K. Shetty
Keyword(s):  
Optic Neuropathy ◽  
Takayasu Arteritis ◽  
Anterior Ischemic Optic Neuropathy ◽  
Ischemic Optic Neuropathy ◽  
Tonic Pupil
Sign in / Sign up

Export Citation Format

Share Document